Envision is the new in-office standard revolutionizing procedures in small and delicate areas. This groundbreaking, nonsurgical device, allows for safe and highly efficacious dermatological procedures in the skin and subdermal layers of the face and periorbital region. This intelligent programmable workstation provides customizable treatments to address common eye conditions such as dry eyes caused by Meibomian Gland Dysfunction (MGD). With Envision, practitioners deliver energy-based therapies to improve patient's skin appearance and quality of life.
KEY BENEFITS
•
Envision deploys multiple complementary modalities which work synergistically:
Forma-I is Health Canada certified to address the symptoms of dry eye disease caused by Meibomian Gland Dysfunction (MGD). It is intended for use in the periorbital area and eyelids, and relieves inflammation of meibomian glands and eye irritation. Forma-I is an innovative thermal technology designed to deliver targeted bipolar radiofrequency energy to small delicate zones.
Lumecca, with the detachable Lumecca-I adaptor, delivers precise, targeted IPL procedures for treatment of superficial vascular and pigmented lesion. Lumecca has built-in features to minimize discomfort and protect the skin, such as cooling mechanisms. Some patients see visible results immediately after the first session, while for others, improvements may become more apparent over time.
Morpheus8 is a minimally invasive device for dermatological fractional coagulation of subcutaneous tissue. Morpheus8 has a portfolio of interchangable microneedling tips that can be adjusted for depth and intensity to target specific skin concerns and areas. This customization allows for personalized treatment plans tailored to individual needs.
Forma is an innovative thermal technology that deploys targeted bipolar radiofrequency energy to dermal and subdermal layers, delivering non-invasive, pain-free procedures. Forma delivers controlled heat to stimulate collagen production and promote tissue remodeling.